SCHEDULE 13G/A

Terns Pharmaceuticals Inc

Common Stock, $0.0001 par value per share (the "Shares") · CUSIP: 880881107

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Citadel Advisors LLC

  Shares: 3,267,779.00 · Class: 3.9%

• Citadel Advisors Holdings LP

  Shares: 3,267,779.00 · Class: 3.9%

• Citadel GP LLC

  Shares: 3,267,779.00 · Class: 3.9%

• Citadel Securities LLC

  Shares: 197,528.00 · Class: 0.2%

• Citadel Securities Group LP

  Shares: 197,528.00 · Class: 0.2%

• Citadel Securities GP LLC

  Shares: 197,528.00 · Class: 0.2%

• Kenneth Griffin

  Shares: 3,465,307.00 · Class: 4.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.